In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?

被引:29
作者
Andrei, G [1 ]
De Clercq, E [1 ]
Snoeck, R [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
varicella-zoster virus; drug-resistant mutants; acyclovir; penciclovir;
D O I
10.1016/j.antiviral.2003.10.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Varicella-zoster virus (VZV) mutants were isolated under the pressure of different classes of antiviral compounds: (i) drugs that depend on the viral thymidine kinase (TK) for their activation, i.e. acyclovir (ACV), brivudin (BVDU), penciclovir (PCV) and sorivudine (BVaraU); (ii) drugs that are independent of the viral TK for their activation, i.e. 2-phosphonylmethoxyethyl (PME) derivatives of adenine (PMEA, adefovir) and 2,6-diaminopurine (PMEDAP); and (iii) drugs that do not require any metabolism to inhibit the viral DNA polymerase, i.e. foscarnet (PFA). Drug-resistant virus strains were obtained by serial passage of the OKA strain in human embryonic lung (HEL) fibroblasts and the different drug-resistant mutants were subsequently evaluated for their in vitro susceptibility to a broad range of antiviral drugs. Virus strains emerging under the pressure of ACV, BVDU and BVaraU were cross-resistant to all drugs that depend on the viral TK for activation, but remained susceptible to the acyclic nucleoside phosphonates (i.e. PMEA, PMEDAP and the 3-hydroxy-2-phosphonylmethoxypropyl derivatives of adenine (HPMPA) and cytosine (HPMPC, cidofovir)) and PFA. In contrast, the virus strains selected under pressure of PCV were resistant to PCV, ACV, PMEA and PFA; but not BVDU, BVaraU, GCV, HPMPC or HPMPA. Similar patterns of drug susceptibility were noted for the virus strains selected under the pressure of PMEA or PFA, pointing to an alteration in the viral DNA polymerase as basis for the resistant phenotype selected by PCV, as well as PMEA and PFA. In contrast, the resistant phenotype selected by ACV as well as BVDU and BVaraU may be attributed primarily to mutations in the viral TK gene. Our data thus indicate that ACV and PCV select in vitro for different drug-resistant VZV phenotypes; whether this is also the situation in vivo remains to be investigated. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 42 条
  • [31] Difference in incidence of spontaneous mutations between herpes simplex virus types 1 and 2
    Sarisky, RT
    Nguyen, TT
    Duffy, KE
    Wittrock, RJ
    Leary, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1524 - 1529
  • [32] Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir
    Sarisky, RT
    Quail, MR
    Clark, PE
    Nguyen, TT
    Halsey, WS
    Wittrock, RJ
    Bartus, JO
    Van Horn, MM
    Sathe, GM
    Van Horn, S
    Kelly, MD
    Bacon, TH
    Leary, JJ
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (04) : 1761 - 1769
  • [33] Schmader K, 2001, CLIN INFECT DIS, V32, P1481, DOI 10.1086/320169
  • [34] SUSCEPTIBILITY OF OKA VARICELLA VACCINE STRAIN TO ANTIVIRAL DRUGS
    SHIRAKI, K
    MATSUI, S
    AIBA, N
    [J]. VACCINE, 1993, 11 (14) : 1380 - 1382
  • [35] ACYCLOVIR-RESISTANT VARICELLA ZOSTER RESPONSIVE TO FOSCARNET
    SMITH, KJ
    DAVIS, C
    JAMES, WD
    SKELTON, HG
    ANGRITT, P
    [J]. ARCHIVES OF DERMATOLOGY, 1991, 127 (07) : 1069 - 1071
  • [36] Current pharmacological approaches to the therapy of varicella zoster virus infections - A guide to treatment
    Snoeck, R
    Andrei, G
    De Clercq, E
    [J]. DRUGS, 1999, 57 (02) : 187 - 206
  • [37] MENINGORADICULONEURITIS DUE TO ACYCLOVIR-RESISTANT VARICELLA-ZOSTER VIRUS IN AN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME PATIENT
    SNOECK, R
    GERARD, M
    SADZOTDELVAUX, C
    ANDREI, G
    BALZARINI, J
    REYMEN, D
    AHADI, N
    DEBRUYN, JM
    PIETTE, J
    RENTIER, B
    CLUMECK, N
    DECLERCQ, E
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1994, 42 (04) : 338 - 347
  • [38] Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro
    Snoeck, R
    Andrei, G
    DeClercq, E
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (07) : 574 - 579
  • [39] ANALYSIS OF THE THYMIDINE KINASE GENES FROM ACYCLOVIR-RESISTANT MUTANTS OF VARICELLA-ZOSTER VIRUS ISOLATED FROM PATIENTS WITH AIDS
    TALARICO, CL
    PHELPS, WC
    BIRON, KK
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (02) : 1024 - 1033
  • [40] Vere Hodge R. A., 1993, Antiviral Chemistry and Chemotherapy, V4, P13